SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-15-003081
Filing Date
2015-10-19
Accepted
2015-10-19 16:05:53
Documents
8
Period of Report
2015-10-19

Document Format Files

Seq Description Document Type Size
1 6-K zk1517415.htm 6-K 15993
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 509880
  Complete submission text file 0001178913-15-003081.txt   3315189

Data Files

Seq Description Document Type Size
3 INSTANCE DOCUMENT fomx-20150630.xml EX-101.INS 541718
4 TAXONOMY EXTENSION SCHEMA fomx-20150630.xsd EX-101.SCH 25255
5 TAXONOMY EXTENSION CALCULATION LINKBASE fomx-20150630_cal.xml EX-101.CAL 49941
6 TAXONOMY EXTENSION DEFINITION LINKBASE fomx-20150630_def.xml EX-101.DEF 133415
7 TAXONOMY EXTENSION LABEL LINKBASE fomx-20150630_lab.xml EX-101.LAB 506369
8 TAXONOMY EXTENSION PRESENTATION LINKBASE fomx-20150630_pre.xml EX-101.PRE 249566
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36621 | Film No.: 151164304
SIC: 2833 Medicinal Chemicals & Botanical Products